Drug Profile
SDZ MKS 492
Alternative Names: MKS 492Latest Information Update: 15 Jun 1995
Price :
$50
*
At a glance
- Originator Novartis
- Class
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 15 Jun 1995 Discontinued-I for Asthma in Switzerland (Inhalation)
- 15 Jun 1995 Discontinued-I for Asthma in Switzerland (PO)
- 15 Jun 1995 Discontinued-I for Asthma in United Kingdom (Inhalation)